Burney Co. Buys New Holdings in Doximity, Inc. (NASDAQ:DOCS)

Burney Co. purchased a new position in Doximity, Inc. (NASDAQ:DOCS) during the fourth quarter, HoldingsChannel reports. The fund purchased 33,902 shares of the company’s stock, valued at approximately $1,810,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in DOCS. American Century Companies Inc. lifted its holdings in shares of Doximity by 0.9% in the second quarter. American Century Companies Inc. now owns 209,772 shares of the company’s stock worth $5,867,000 after buying an additional 1,786 shares in the last quarter. Federated Hermes Inc. lifted its stake in Doximity by 1,824.5% in the 2nd quarter. Federated Hermes Inc. now owns 279,634 shares of the company’s stock worth $7,821,000 after purchasing an additional 265,104 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in shares of Doximity by 48.2% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 22,705 shares of the company’s stock valued at $635,000 after purchasing an additional 7,385 shares during the last quarter. Envestnet Asset Management Inc. grew its position in shares of Doximity by 16.5% during the second quarter. Envestnet Asset Management Inc. now owns 148,584 shares of the company’s stock valued at $4,156,000 after purchasing an additional 21,005 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Doximity by 28.5% in the second quarter. Dimensional Fund Advisors LP now owns 1,267,067 shares of the company’s stock worth $35,439,000 after purchasing an additional 281,239 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors.

Doximity Stock Up 4.4 %

DOCS opened at $53.02 on Thursday. The business has a fifty day moving average of $53.40 and a 200 day moving average of $42.09. The stock has a market cap of $9.90 billion, a P/E ratio of 60.94, a PEG ratio of 4.13 and a beta of 1.38. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $61.75.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Wells Fargo & Company increased their price target on Doximity from $41.00 to $43.00 and gave the company an “equal weight” rating in a research note on Monday. Barclays increased their target price on Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research report on Monday, November 11th. Canaccord Genuity Group restated a “hold” rating and issued a $60.00 price target (up previously from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Evercore ISI upped their price target on shares of Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Finally, Truist Financial lifted their price objective on shares of Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a research note on Thursday, November 14th. Thirteen investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $53.12.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.